Phase II study of modified FOLFIRINOX for chemotherapy-naïve patients with metastatic pancreatic cancer (MPC)

Background: FOLFIRINOX is considered one of the standard chemotherapy regimens for chemotherapy-naïve pts. with MPC, but carries an unfavorable adverse event (AE) profile.

Bibliographische Detailangaben

Veröffentlicht in:	Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] Jg. 16; H. 4; S. S30 - S31
Hauptverfasser:	Ozaka, Masato, Ishii, Hiroshi, Sato, Tosiya, Ueno, Makoto, Ikeda, Masafumi, Uesugi, Kazuhiro, Sata, Naohiro, Miyashita, Kouichirou, Mizuno, Nobumasa, Tsuji, Kunihiro, Okusaka, Takuji, Furuse, Junji
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	Philadelphia Elsevier B.V 01.08.2016 Elsevier Limited
Schlagworte:	Chemotherapy Confidence intervals Endocrinology & Metabolism Gastroenterology and Hepatology Metastasis Neutropenia Pancreatic cancer
ISSN:	1424-3903, 1424-3911
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!